Walgreens Boots Alliance Inc (WBA) FinancialsWBAWalgreens Boots Alliance Inc

Walgreens Boots Alliance Inc (WBA) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Pharmacy, accounting for 64.9% of total sales, equivalent to $25.29B. Other significant revenue streams include Retail and Wholesale. Understanding this composition is critical for investors evaluating how WBA navigates market cycles within the Drug Retailers industry.

Evaluating the bottom line, Walgreens Boots Alliance Inc maintains a gross margin of 16.69%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 0.77%, while the net margin is -0.50%. These profitability ratios, combined with a Return on Equity (ROE) of -60.48%, provide a clear picture of how effectively WBA converts its operational activities into shareholder value.

In the context of the broader market, WBA competes directly with industry leaders such as GRDN and CVS. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, WBA's gross margin of 16.69% stands against GRDN's 22.75% and CVS's 14.84%. Such benchmarking helps identify whether Walgreens Boots Alliance Inc is trading at a premium or discount relative to its financial performance.